The role of ultrasound in the detection of endometrial pathologies in asymptomatic postmenopausal breast cancer patients with tamoxifen treatment.
Transvaginal ultrasonography is an effective diagnostic procedure, and thus, it can reasonably be used to determine which asymptomatic, postmenopausal breast cancer patient with tamoxifen treatment will require endometrial sampling. Overall, it seems that the contribution of pulsed Doppler flow in the diagnosis of endometrial pathologies in such patients is nonconclusive. It is suggested that sonohysterography is a useful diagnostic tool for the assessment of specific endometrial pathologies, especially of space-occupying lesions in the endometrial cavity, in such patients.
Cohen
I
I
Department of Obstetrics and Gynecology, Sapir Medical Center, Tel Aviv University, Israel.
Beyth
Y
Y
Tepper
R
R
D000359:Aftercare; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003663:Decision Trees; D016903:Drug Monitoring; D004714:Endometrial Hyperplasia / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D019160:Endosonography; D005260:Female; D006801:Humans; D007047:Hysterosalpingography; D008875:Middle Aged; D017698:Postmenopause; D013629:Tamoxifen / Q000009:adverse effects*; D018615:Ultrasonography, Doppler, Color; D018617:Ultrasonography, Doppler, Pulsed; D014621:Vagina
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen